Noro-Moseley Partners IX, L.P.
Open, writing first checks
Open: first sale Oct 2022, per Form D (fund age approximates vintage)
- Vintage
- 2022
- Fund size
- $153.77M to $167.85M (Form D and SEC adviser filing)
- Stages
- Not stated
- Sectors
- Enterprise SaaS, Cybersecurity, Healthtech, Fintech
- Regions
- US
01 · Thesis
Noro-Moseley Partners makes early growth equity investments in rapidly scaling B2B technology and healthcare companies. It looks for year-over-year growth of 50%+, compelling unit economics, and significant opportunities for market disruption, typically among companies with minimal prior funding.Inferred from the firm's website
02 · Initial check
$1.54M to $2.8M (estimated from fund size)
Estimated from Form D and SEC adviser filing
03 · Who to approach
Named on this fund's Form D
- W. McClelland, A controlling member of the General Partner.
- John Ale, Jr., A controlling member of the General Partner.
- Bill Hudson, Administrative Partner, CFO
- Alan Taetle, A controlling member of the General Partner.
- Allen Moseley, A controlling member of the General Partner.
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideEarly growth equity for rapidly-scaling B2B technology and healthcare companies.
Early growth equity for rapidly-scaling B2B technology and healthcare companies
https://noromoseley.com/
06 · Sources
Last verified: Oct 28, 2026